Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions.
However, most common product type and intent of use associated with these visits vary by age.
At age 55 years, remaining lifetime risk of diabetes in the high genetic risk group was 23.5 percent for those in ideal cardiovascular health.
Researchers addressed common misconceptions regarding the diagnosis and treatment of gastroparesis.
Investigators assessed the relationship among lean or fatty fish intake, fatty acid supplements, and lowered severity of type 2 diabetes in women following pregnancy.
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Researchers assessed the amount of weight loss necessary to achieve initial remission of type 2 diabetes mellitus following bariatric surgery.
People diagnosed with type 2 diabetes can eventually achieve normal glucose levels. But whether or when this means a person is “in remission” was the subject of an international group of experts convened by the American Diabetes Association.
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
Investigators assessed the effect of efpeglenatide, an exendin-based glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes at increased risk for cardiovascular events.
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
Overweight or obese adults should be screened for prediabetes, type 2 diabetes and offered or referred for preventive interventions
July 2021 FDA drug approvals include treatments for T2D in adolescents, trichomoniasis, and acne vulgaris, as well as a vaccine for pneumococcal diseases.
Researchers studied the effect of dietary L-arginine on the incidence of type 2 diabetes.
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Researchers studied the effectiveness of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin without prandial insulin in primary care practices.
One of the researchers’ goals was to investigate the association between newly detected disturbances of glucose metabolism and long-term prognosis after AMI.
Researchers assessed how gut microbiota changes are associated with anthropometric, metabolic, and inflammatory profiles following metabolic surgery in adults with type 2 diabetes and mild obesity.